Tag: cell

SUNNYVALE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioCardia^®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the three months ended June 30, 2025 by conference call on Monday, August 11, 2025 at 4:30 PM ET. Following management’s formal remarks, there will be a question-and-answer session.

TAIPEI, Taiwan, Aug. 06, 2025 (GLOBE NEWSWIRE) -- “More than ever, this is the moment for the intellect and efforts of Vietnamese, both domestic and abroad, to prove that we can achieve what once seemed impossible.” This heartfelt call from CT Group’s Chairman resonated throughout the "Vietnam Dreams Come True" conference held on July 25, 2025, in Taiwan, inspiring a community of intellectuals, experts, and overseas Vietnamese living, studying, and working abroad.

– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) –

CORAL GABLES, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced the National Comprehensive Cancer Network^® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Small Cell Lung Cancer (SCLC) now include new additions involving Lambert Eaton myasthenic syndrome (LEMS), amifampridine (FIRDAPSE^®), and the tests for PQ- and N-type voltage-gated calcium channel (VGCC) antibodies.